HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

xibornol

structure

Also Known As:

6-isobornyl-3,4-xylenol; Bracen; bactacine; nanbacine

Networked: 11 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Carducci, Annalaura: 1 article (06/2022)
2.	Federigi, Ileana: 1 article (06/2022)
3.	Lauretani, Giulia: 1 article (06/2022)
4.	Muzio, Sara: 1 article (06/2022)
5.	Verani, Marco: 1 article (06/2022)
6.	Battaglia, Santina: 1 article (01/2022)
7.	Bigini, Cristina: 1 article (01/2022)
8.	Calvigioni, Marco: 1 article (01/2022)
9.	Ceccanti, Stefano: 1 article (01/2022)
10.	Celandroni, Francesco: 1 article (01/2022)

Related Diseases

1.	Infections 07/01/1984 - "[Clinical evaluation of the therapeutic efficacy of xibornol in acute infections in chronic pulmonary diseases (controlled clinical study)]." 01/01/2022 - "Xibornol is known since the 70s and a xibornol-based formulation is commercialized as spray suspension for the antisepsis of the oral cavity and as adjuvant in pharyngeal infections caused by Gram-positive microorganisms. " 08/01/2007 - "Xibornol is a lipophilic drug mainly used in Italy and Spain in spray dosage forms for the local treatment of infection and inflammation of the throat. "
2.	Lung Diseases (Lung Disease) 07/01/1984 - "[Clinical evaluation of the therapeutic efficacy of xibornol in acute infections in chronic pulmonary diseases (controlled clinical study)]."
3.	Respiratory Tract Infections (Respiratory Tract Infection) 01/01/1982 - "A comparison of Bracen and co-trimoxazole in the treatment of acute respiratory tract infections in children." 01/01/1982 - "A comparison of Bracen and ampicillin in the treatment of acute respiratory tract infections in children." 01/01/1982 - "A comparison of Bracen and penicillin V in the treatment of acute respiratory tract infections in children."
4.	Chronic Bronchitis 01/01/1988 - "In ten patients with severe chronic bronchitis and in a further 23 with planned resection of lung, tonsils or larynx, 500 mg doses, single or multiple, of xibornol (6-isobronyl-3, 4-xylenol) were administered for an antibacterial effect. " 02/15/1985 - "[Efficacy and tolerability of a new chemotherapeutic agent in the treatment of recurrent chronic bronchitis: xibornol]."
5.	Respiratory Tract Diseases (Respiratory Tract Disease) 01/01/2023 - "The obtained data confirmed Xibornol activity and its use as topic substance for viral inactivation to prevent upper respiratory tract disease." 06/01/1984 - "Since many antimicrobial drugs have been reported to inhibit phagocyte function, we tested the interference of xibornol, a new antimicrobial agent, on phagocyte functions, in order to evaluate its possible use in chronic respiratory diseases. "

Related Drugs and Biologics

1.	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
2.	Suspensions
3.	Penicillin V (Phenoxymethylpenicillin)
4.	Dosage Forms (Dosage Form)
5.	Anti-Bacterial Agents (Antibiotics)
6.	Anti-Infective Agents (Microbicides)
7.	Ampicillin (Omnipen)